News

Innoslim is a clinically validated natural calorie-reducing and metabolism-boosting nutraceutical derived from the Notoginseng and Astragalus plants. The dietary ingredient has been shown in cell and animal studies

The tie up allows Crucell to use Pepscan’s proprietary technology to develop new vaccines targeting infectious diseases. As per the terms of the agreement, Crucell is responsible to

NanoCrystal technology was developed by EDT through Elan Pharma International Limited and other Elan affiliates. EDT, the drug delivery unit of Elan Corporation, said the NanoCrystal technology enables

Merck has filed the NDA to support the proposed use of Saflutan for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular

The company reported net loss was $2.74m, compared to a net income of $2.15m for the same period in 2009. Mannatech’s loss from operations was $2.8m for the

Belimumab, the first in a new class of drugs called BLyS-specific inhibitors, blocks the binding of soluble BLyS, a B-cell survival factor, to its receptors on B cells.

The patent application ‘Modular Method to Prepare Tetrameric Cytokines with Improved Pharmacokinetics by the Dock-and-Lock (DNL) Technology’ will issue as US Patent no. 7,906,118 on 15 March 2011.

eStudy is a 100% web-based study management platform that iAdvantage Software hosts for BTS at Cegidem/Dendrite’s network operating center in Chesapeake, Virginia. iAdvantage Marketing and Sales Director Diana

KineMed is a biotechnology company specialized in translational and personalized medicine. As per the agreement, KineMed has given license to its technologies to Bristol-Myers Squibb for identifying and